DK175249B1 - Doseringsform til kontrolleret afgivelse - Google Patents

Doseringsform til kontrolleret afgivelse Download PDF

Info

Publication number
DK175249B1
DK175249B1 DK198806180A DK618088A DK175249B1 DK 175249 B1 DK175249 B1 DK 175249B1 DK 198806180 A DK198806180 A DK 198806180A DK 618088 A DK618088 A DK 618088A DK 175249 B1 DK175249 B1 DK 175249B1
Authority
DK
Denmark
Prior art keywords
coating layer
diltiazem
ethyl cellulose
dosage form
granules
Prior art date
Application number
DK198806180A
Other languages
Danish (da)
English (en)
Other versions
DK618088D0 (da
DK618088A (da
Inventor
Masayoshi Samejima
Kazuo Noda
Masao Kobayashi
Shigeyuki Ishikawa
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of DK618088D0 publication Critical patent/DK618088D0/da
Publication of DK618088A publication Critical patent/DK618088A/da
Application granted granted Critical
Publication of DK175249B1 publication Critical patent/DK175249B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK198806180A 1987-11-06 1988-11-04 Doseringsform til kontrolleret afgivelse DK175249B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28118987 1987-11-06
JP28118987 1987-11-06

Publications (3)

Publication Number Publication Date
DK618088D0 DK618088D0 (da) 1988-11-04
DK618088A DK618088A (da) 1989-05-07
DK175249B1 true DK175249B1 (da) 2004-07-19

Family

ID=17635585

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198806180A DK175249B1 (da) 1987-11-06 1988-11-04 Doseringsform til kontrolleret afgivelse

Country Status (24)

Country Link
US (1) US4963365A (hu)
EP (1) EP0315414B1 (hu)
KR (1) KR940002655B1 (hu)
CN (1) CN1035099C (hu)
AT (1) ATE68343T1 (hu)
AU (1) AU610275B2 (hu)
BG (1) BG60638B1 (hu)
CA (1) CA1331565C (hu)
DE (1) DE3865631D1 (hu)
DK (1) DK175249B1 (hu)
ES (1) ES2027013T3 (hu)
FI (1) FI96273C (hu)
FR (1) FR2622799B1 (hu)
GR (1) GR3002915T3 (hu)
HK (1) HK44593A (hu)
HU (1) HU201468B (hu)
IE (1) IE60785B1 (hu)
IL (1) IL88083A (hu)
NO (1) NO176233C (hu)
PH (1) PH25905A (hu)
PT (1) PT88945B (hu)
RU (1) RU1816213C (hu)
SG (1) SG15493G (hu)
ZA (1) ZA888147B (hu)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
EP0386440B1 (de) * 1989-02-11 1992-08-05 Bayer Ag Arzneimittel mit kontrollierter Wirkstoffabgabe
US5258186A (en) * 1989-03-10 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Drug release controlling coating material for long acting formulations
US5886012A (en) * 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
JP2919607B2 (ja) * 1989-03-22 1999-07-12 ピーター ケー テイー パング パラシロイド高血圧性因子
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
JP3426230B2 (ja) * 1991-05-20 2003-07-14 アベンティス・ファーマスーティカルズ・インコーポレイテッド 複数層の制御放出処方剤
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
US5252337A (en) * 1991-06-25 1993-10-12 Eurand America, Inc. Controlled release calcium channel blocker microcapsules
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
US5492700A (en) * 1991-11-26 1996-02-20 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
EP0571973B1 (en) * 1992-05-29 2000-02-02 Nikken Chemicals Co., Ltd. Slow-release sodium valproate tablets
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
US5447729A (en) * 1994-04-07 1995-09-05 Pharmavene, Inc. Multilamellar drug delivery systems
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
DE69732983T2 (de) * 1996-09-13 2006-02-16 Shionogi & Co., Ltd. Zubereitung mit verlängerter freisetzung unter verwendung einer thermischen umwandlung sowie verfahren zu deren herstellung
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US6699508B1 (en) 1998-08-10 2004-03-02 Asahi Kasei Pharma Corporation Sustained release oral preparations of fasudil hydrochloride
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
US6946146B2 (en) 2001-04-18 2005-09-20 Nostrum Pharmaceuticals Inc. Coating for a sustained release pharmaceutical composition
US20040029959A1 (en) * 2002-08-08 2004-02-12 John Devane Isosorbide mononitrate compositions and methods of their use
US9107804B2 (en) * 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
CA2529984C (en) 2003-06-26 2012-09-25 Isa Odidi Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
CN1296046C (zh) * 2003-12-23 2007-01-24 广州市医药工业研究所 盐酸地尔硫䓬控释胶囊剂及其制备方法
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
JP5649784B2 (ja) 2006-02-07 2015-01-07 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ 組成物、基材を組成物でコーティングする方法、被覆基材、製品、フィルム、ペレット、タブレット及びカプセル
JP5457830B2 (ja) 2006-04-03 2014-04-02 オディディ，イサ オルガノゾル被膜を含む制御放出送達デバイス
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US8927010B2 (en) * 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) * 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9119809B2 (en) * 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8916588B2 (en) * 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
EP2529731A1 (en) * 2011-06-01 2012-12-05 Nitto Denko Corporation Particulate preparation and method for producing the same
FR2996418B1 (fr) * 2012-10-09 2015-05-29 Seppic Sa Compositions alimentaires comprenant des capsules obtenues par coacervation ne mettant pas en œuvre de reticulant toxique
EP2919903B1 (en) 2012-11-14 2020-07-22 W.R. Grace & CO. - CONN. Compositions containing a biologically active material and a non-ordered inorganic oxide

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857550A (en) * 1956-01-25 1960-12-29 Lowey Hans Improvements in or relating to the coating of shaped medical preparations
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
IT1153487B (it) * 1982-04-15 1987-01-14 Prophin Lab Spa Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
US4390406A (en) * 1982-07-23 1983-06-28 Allied Corporation Replaceable outer junction double junction reference electrode
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE3403329A1 (de) * 1984-02-01 1985-08-01 Horst Dr. 4019 Monheim Zerbe Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4851228A (en) * 1984-06-20 1989-07-25 Merck & Co., Inc. Multiparticulate controlled porosity osmotic
US4600645A (en) * 1985-01-31 1986-07-15 Warner-Lambert Company Process for treating dosage forms
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins

Also Published As

Publication number Publication date
DK618088D0 (da) 1988-11-04
HU201468B (en) 1990-11-28
AU2472788A (en) 1989-05-11
GR3002915T3 (en) 1993-01-25
NO884947D0 (no) 1988-11-04
FR2622799A1 (fr) 1989-05-12
HK44593A (en) 1993-05-14
IE883246L (en) 1989-05-06
FI96273C (fi) 1996-06-10
NO884947L (no) 1989-05-08
PH25905A (en) 1991-12-19
CN1033007A (zh) 1989-05-24
AU610275B2 (en) 1991-05-16
EP0315414B1 (en) 1991-10-16
NO176233B (no) 1994-11-21
DK618088A (da) 1989-05-07
BG60638B1 (bg) 1995-11-30
SG15493G (en) 1993-04-16
FI885101A (fi) 1989-05-07
IL88083A0 (en) 1989-06-30
EP0315414A1 (en) 1989-05-10
PT88945B (pt) 1993-05-31
IE60785B1 (en) 1994-08-10
ATE68343T1 (de) 1991-11-15
ZA888147B (en) 1990-06-27
KR890007720A (ko) 1989-07-05
BG85941A (bg) 1993-12-24
ES2027013T3 (es) 1992-05-16
NO176233C (no) 1995-03-01
RU1816213C (ru) 1993-05-15
CA1331565C (en) 1994-08-23
FI885101A0 (fi) 1988-11-04
PT88945A (pt) 1989-11-30
KR940002655B1 (ko) 1994-03-28
CN1035099C (zh) 1997-06-11
US4963365A (en) 1990-10-16
HUT50624A (en) 1990-03-28
IL88083A (en) 1992-11-15
FR2622799B1 (fr) 1991-11-29
FI96273B (fi) 1996-02-29
DE3865631D1 (de) 1991-11-21

Similar Documents

Publication Publication Date Title
DK175249B1 (da) Doseringsform til kontrolleret afgivelse
US4221778A (en) Prolonged release pharmaceutical preparations
US4663150A (en) Sustained absorption pharmaceutical composition
EP0527637B1 (en) Spheroids containing dittiazem and a spheronizing agent
US4772475A (en) Controlled-release multiple units pharmaceutical formulation
US4524060A (en) Slow release pharmaceutical composition
JPH0530804B2 (hu)
US20020031550A1 (en) Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3yl) acetonitrile monohydrochloride
NO883326L (no) Dhp-retard-tilberedning.
US4966772A (en) DHP delayed release preparation
NO852880L (no) Fremgangsmaate ved fremstilling av farmasoeytisk preparat med forsinket frigjoering
WO2004110410A1 (en) Extended release composition containing tramadol
JPH07552B2 (ja) 持効性製剤
AU719075B2 (en) Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance
AU724086B2 (en) Controlled release dosage form of (R-(Z))-alpha- (methoxyimino)-alpha-(1-azabicyclo(2.2.2)oct-3-yl) acetonitrile monohydrochloride
KR0133531B1 (ko) 액체 약제 제형용 서방성 치료 시스템
FI65910C (fi) Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan
IE64705B1 (en) Oral formulation of buspirone and salts thereof
JPH04103525A (ja) 難水溶性薬物の持続性製剤化方法
JPH01313431A (ja) ジルチアゼム・マイクロビーズ、その製法および徐放性医薬組成物
GB2258613A (en) Pharmaceutical diltiazem spheroid formulation
MXPA99002404A (en) Controlled release dosage form of [r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2. 2]oct-3-yl)acetonitrile monohydrochloride
El-Deen et al. DESIGN AND EVALUATION OF ENTERIC COATED FORMULATIONS FOR AN ANTI-INFLAMMATORY DRUG BASED ON MODIFIED RELEASE POLYMERS
SK111595A3 (en) Remedial preparation containing morphine sulfate and preparation method thereof

Legal Events

Date Code Title Description
PUP Patent expired